retatrutide nonalcoholic fatty liver disease nash trial Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic liver (MASLD), formerly liver disease. This MASH in Type 2 Diabetes:
Description
Diabetes Ther, 2023, Vol 14, pp 723736
Another key point: stopping therapy leads to regain in most people, which argues for getting to and staying at an effective maintenance dose rather than hovering at subtherapeutic levels
Eat cooked vegetables instead of raw to reduce fiber load while maintaining nutrients, she says
Jolene Brighton
95% confidence interval [CI]: 0.79-0.94
However, the key differences in how hair loss presents for different sexes mostly applies to what health professionals call pattern baldness
